Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.33B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.56B |
| 3 |
CRH
CRH
|
+$714M |
| 4 |
Microsoft
MSFT
|
+$474M |
| 5 |
Apple
AAPL
|
+$447M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.41B |
| 2 |
Toronto Dominion Bank
TD
|
+$598M |
| 3 |
Bank of Montreal
BMO
|
+$539M |
| 4 |
Canadian Natural Resources
CNQ
|
+$520M |
| 5 |
Starbucks
SBUX
|
+$510M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18% |
| 2 | Financials | 17.34% |
| 3 | Industrials | 7.44% |
| 4 | Healthcare | 7.19% |
| 5 | Consumer Discretionary | 6.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XDOC
5901
DELISTED
Innovator US Equity Accelerated ETF October
XDOC
| $24K | ﹤0.01% |
+813
| New | +$23.3K |
|
5902
Zentalis Pharmaceuticals
ZNTL
$255M
| $24K | ﹤0.01% |
5,900
+3,018
| +105% | +$33.7K |
|
|
TBCH
5903
Turtle Beach Corp
TBCH
$228M
| $24K | ﹤0.01% |
1,700
+1,246
| +274% | +$19.4K |
|
5904
Aprea Therapeutics
APRE
$8.42M
| $23K | ﹤0.01% |
5,694
+3,124
| +122% | +$16.1K |
|
5905
BARK
BARK
$91.4M
| $23K | ﹤0.01% |
626
+474
| +312% | +$12.1K |
|
5906
Backblaze
BLZE
$1.18B
| $23K | ﹤0.01% |
3,754
+3,684
| +5,263% | +$28.7K |
|
5907
dLocal
DLO
$4.17B
| $23K | ﹤0.01% |
2,835
+1,603
| +130% | +$18.8K |
|
|
LKFT
5908
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.8B
| $23K | ﹤0.01% |
967
+54
| +6% | +$1.53K |
|
5909
Garrett Motion
GTX
$5.41B
| $23K | ﹤0.01% |
2,733
-2,604
| -49% | -$24.1K |
|
|
ILPT
5910
Industrial Logistics Properties Trust
ILPT
$595M
| $23K | ﹤0.01% |
6,143
-70,026
| -92% | -$271K |
|
5911
Korro Bio
KRRO
$196M
| $23K | ﹤0.01% |
675
+578
| +596% | +$31.9K |
|
5912
PepGen
PEPG
$207M
| $23K | ﹤0.01% |
1,471
+1,236
| +526% | +$17.7K |
|
5913
Invesco Dorsey Wright Energy Momentum ETF
PXI
$55.5M
| $23K | ﹤0.01% |
475
-655
| -58% | -$31.5K |
|
5914
Simplify US Equity PLUS Downside Convexity ETF
SPD
$107M
| $23K | ﹤0.01% |
+700
| New | +$21.9K |
|
5915
Sutro Biopharma
STRO
$340M
| $23K | ﹤0.01% |
770
+628
| +442% | +$24.8K |
|
5916
Transportadora de Gas del Sur
TGS
$4.23B
| $23K | ﹤0.01% |
1,205
-979
| -45% | -$17.6K |
|
|
TSE
5917
DELISTED
Trinseo
TSE
| $23K | ﹤0.01% |
9,959
+8,534
| +599% | +$26.6K |
|
5918
Innovator US Equity Ultra Buffer ETF October
UOCT
$181M
| $23K | ﹤0.01% |
671
-6,335
| -90% | -$214K |
|
5919
FibroBiologics
FBLG
$7.06M
| $23K | ﹤0.01% |
231
+211
| +1,055% | +$40.2K |
|
5920
Arq
ARQ
$102M
| $23K | ﹤0.01% |
+3,805
| New | +$26.2K |
|
|
LENZ
5921
LENZ Therapeutics
LENZ
$149M
| $23K | ﹤0.01% |
1,342
+1,249
| +1,343% | +$21.8K |
|
|
CGHM
5922
Capital Group Municipal High-Income ETF
CGHM
$3.3B
| $23K | ﹤0.01% |
+900
| New | +$22.5K |
|
|
PSTX
5923
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $23K | ﹤0.01% |
7,684
+4,865
| +173% | +$13.3K |
|
5924
AlTi Global
ALTI
$444M
| $22K | ﹤0.01% |
4,078
+3,370
| +476% | +$16.2K |
|
5925
Aveanna Healthcare
AVAH
$2.68B
| $22K | ﹤0.01% |
7,916
+3,782
| +91% | +$9.43K |
|
Similar funds
Royal Bank of Canada's Q2 2024 Portfolio in Review
As of Q2 2024, Royal Bank of Canada held 7,823 positions worth $439B, up 0.73% from $436B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Royal Bank of Canada's Q2 2024 filing shows 420 new, 3,917 increased, 2,460 reduced and 394 closed positions. Its largest new stake was AB Short Duration High Yield ETF: 1,113,155 shares worth $39.1M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $3.41B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Financials and Industrials.
- Royal Bank of Canada's largest Q2 2024 buy was AB Short Duration High Yield ETF: 1,113,155 shares worth $39.1M.
- Royal Bank of Canada added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $2.33B increase.
- Royal Bank of Canada's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.41B.
- Royal Bank of Canada fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $142M.
- Royal Bank of Canada's ten largest holdings make up 20% of its $439B portfolio in Q2 2024.
- Royal Bank of Canada opened 420 new positions and closed 394 in Q2 2024.
- Royal Bank of Canada's portfolio value rose 0.73% quarter-over-quarter to $439B.
Based on Royal Bank of Canada's 13F filing for Q2 2024, filed 14 Aug 2024.